{
    "info": {
        "nct_id": "NCT03685175",
        "official_title": "Effect of Cardiotoxic Anticancer Therapy on the Metabolism of [1-13C]Pyruvate in Cardiac Mitochondria",
        "inclusion_criteria": "* Female or male with breast cancer tissue diagnosis or a healthy volunteer.\n* Plan for treatment as cardiotoxic therapy. Patients for the feasibility study must be post cardiotoxic therapy, and patients for the formal study should not have started the cardiotoxic therapy yet.\n* Age ≥ 18 years\n* Ability to understand and the willingness to sign a written informed consent\n* While all races and ethnicities will be included, subjects must be able to read and speak the English language, and or, the Spanish Language.\n* Women of child-bearing potential must agree to use adequate contraception (hormonal or barrier method of birth control; abstinence) prior to study entry, for the duration of study participation. Should a woman become pregnant or suspect she is pregnant while participating in this study, she should inform her treating physician immediately.\n\nA female of childbearing potential is any woman (regardless of sexual orientation, having undergone a tubal ligation, or remaining celibate by choice) who meets the following criteria:\n\n* Has not undergone a hysterectomy or bilateral oophorectomy; or\n* Has not been naturally postmenopausal for at least 12 consecutive months (i.e., has had menses at any time in the preceding 12 consecutive months).\n\n  - Males must be surgically sterile or have a female partner using an acceptable method of contraception.\n* Acceptable surgical sterilization techniques are vasectomy with surgery at least 6 months prior to dosing. Males must also refrain from sperm donation during the study and for 6 months following discontinuation of treatment.\n* Acceptable methods of contraception for female partners of childbearing potential are an intrauterine device, contraceptive implant, and a barrier method (eg. Condom, diaphragm, cervical cap) during the study and for 6 months after patient discontinuation of treatment.\nHealthy volunteers allowed\nMust have minimum age of 18 Years",
        "exclusion_criteria": "* Patients for the feasibility study must be post cardiotoxic therapy\n* Known Type 1 or Type 2 diabetes.\n* Subjects who are receiving any other investigational agents that are not compatible with the study.\n* Subjects with known remote, macro, metastases will be excluded from this clinical trial because of their poor prognosis.\n* Uncontrolled intercurrent illness including, but not limited to, ongoing or active infection, symptomatic congestive heart failure, unstable angina pectoris, cardiac arrhythmia, or psychiatric illness/social situations that would limit compliance with study requirements.\n* Any contraindication per MRI Screening Form (Appendix A attached) including, but not limited to:\n\n  * Metal Implants and devices contraindicated at 3T.\n  * Breast tissue expanders.\n  * Non-MR compatible IV port.\n  * Claustrophobia.\n* Female subjects who are already pregnant.\n* Sickle cell disease\n* Hemolytic anemia\n* If the subject agrees to doing a cardiac function MRI scan with gadolinium based contrast agent intravenously:\n\neGFR ≤ 30 mL/min/1.73m2",
        "miscellaneous_criteria": ""
    },
    "inclusion_lines": [
        {
            "line": "* Ability to understand and the willingness to sign a written informed consent",
            "criterions": [
                {
                    "exact_snippets": "Ability to understand",
                    "criterion": "ability to understand",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "willingness to sign a written informed consent",
                    "criterion": "willingness to sign informed consent",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Acceptable surgical sterilization techniques are vasectomy with surgery at least 6 months prior to dosing. Males must also refrain from sperm donation during the study and for 6 months following discontinuation of treatment.",
            "criterions": [
                {
                    "exact_snippets": "Acceptable surgical sterilization techniques are vasectomy with surgery at least 6 months prior to dosing.",
                    "criterion": "vasectomy",
                    "requirements": [
                        {
                            "requirement_type": "procedure",
                            "expected_value": true
                        },
                        {
                            "requirement_type": "time since surgery",
                            "expected_value": {
                                "operator": ">=",
                                "value": 6,
                                "unit": "months"
                            }
                        }
                    ]
                },
                {
                    "exact_snippets": "Males must also refrain from sperm donation during the study and for 6 months following discontinuation of treatment.",
                    "criterion": "sperm donation",
                    "requirements": [
                        {
                            "requirement_type": "abstinence from sperm donation",
                            "expected_value": true
                        },
                        {
                            "requirement_type": "duration of abstinence",
                            "expected_value": [
                                "during the study",
                                "for 6 months following discontinuation of treatment"
                            ]
                        }
                    ]
                }
            ]
        },
        {
            "line": "- Males must be surgically sterile or have a female partner using an acceptable method of contraception.",
            "criterions": [
                {
                    "exact_snippets": "Males must be surgically sterile",
                    "criterion": "male surgical sterility",
                    "requirements": [
                        {
                            "requirement_type": "sterility",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "have a female partner using an acceptable method of contraception",
                    "criterion": "female partner contraception use",
                    "requirements": [
                        {
                            "requirement_type": "contraception method",
                            "expected_value": "acceptable"
                        }
                    ]
                }
            ]
        },
        {
            "line": "Must have minimum age of 18 Years",
            "criterions": [
                {
                    "exact_snippets": "minimum age of 18 Years",
                    "criterion": "age",
                    "requirements": [
                        {
                            "requirement_type": "minimum",
                            "expected_value": {
                                "operator": ">=",
                                "value": 18,
                                "unit": "Years"
                            }
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Acceptable methods of contraception for female partners of childbearing potential are an intrauterine device, contraceptive implant, and a barrier method (eg. Condom, diaphragm, cervical cap) during the study and for 6 months after patient discontinuation of treatment.",
            "criterions": [
                {
                    "exact_snippets": "female partners of childbearing potential",
                    "criterion": "female partner childbearing potential",
                    "requirements": [
                        {
                            "requirement_type": "potential for childbearing",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "Acceptable methods of contraception ... are an intrauterine device, contraceptive implant, and a barrier method (eg. Condom, diaphragm, cervical cap)",
                    "criterion": "contraception method",
                    "requirements": [
                        {
                            "requirement_type": "method",
                            "expected_value": [
                                "intrauterine device",
                                "contraceptive implant",
                                "barrier method (eg. Condom, diaphragm, cervical cap)"
                            ]
                        }
                    ]
                },
                {
                    "exact_snippets": "during the study and for 6 months after patient discontinuation of treatment",
                    "criterion": "contraception duration",
                    "requirements": [
                        {
                            "requirement_type": "duration",
                            "expected_value": "during the study and for 6 months after patient discontinuation of treatment"
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Female or male with breast cancer tissue diagnosis or a healthy volunteer.",
            "criterions": [
                {
                    "exact_snippets": "Female or male",
                    "criterion": "sex",
                    "requirements": [
                        {
                            "requirement_type": "allowed_values",
                            "expected_value": [
                                "female",
                                "male"
                            ]
                        }
                    ]
                },
                {
                    "exact_snippets": "breast cancer tissue diagnosis",
                    "criterion": "breast cancer tissue diagnosis",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "healthy volunteer",
                    "criterion": "healthy volunteer status",
                    "requirements": [
                        {
                            "requirement_type": "status",
                            "expected_value": "healthy volunteer"
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Age ≥ 18 years",
            "criterions": [
                {
                    "exact_snippets": "Age ≥ 18 years",
                    "criterion": "age",
                    "requirements": [
                        {
                            "requirement_type": "minimum value",
                            "expected_value": {
                                "operator": ">=",
                                "value": 18,
                                "unit": "years"
                            }
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Has not been naturally postmenopausal for at least 12 consecutive months (i.e., has had menses at any time in the preceding 12 consecutive months).",
            "criterions": [
                {
                    "exact_snippets": "Has not been naturally postmenopausal for at least 12 consecutive months",
                    "criterion": "menopausal status",
                    "requirements": [
                        {
                            "requirement_type": "postmenopausal_duration",
                            "expected_value": {
                                "operator": "<",
                                "value": 12,
                                "unit": "months"
                            }
                        }
                    ]
                },
                {
                    "exact_snippets": "has had menses at any time in the preceding 12 consecutive months",
                    "criterion": "menstrual history",
                    "requirements": [
                        {
                            "requirement_type": "menses_in_past_12_months",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "Healthy volunteers allowed",
            "criterions": [
                {
                    "exact_snippets": "Healthy volunteers allowed",
                    "criterion": "healthy volunteer status",
                    "requirements": [
                        {
                            "requirement_type": "eligibility",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "A female of childbearing potential is any woman (regardless of sexual orientation, having undergone a tubal ligation, or remaining celibate by choice) who meets the following criteria:",
            "criterions": [
                {
                    "exact_snippets": "A female of childbearing potential is any woman",
                    "criterion": "sex",
                    "requirements": [
                        {
                            "requirement_type": "sex",
                            "expected_value": "female"
                        }
                    ]
                },
                {
                    "exact_snippets": "A female of childbearing potential",
                    "criterion": "childbearing potential",
                    "requirements": [
                        {
                            "requirement_type": "potential",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Plan for treatment as cardiotoxic therapy. Patients for the feasibility study must be post cardiotoxic therapy, and patients for the formal study should not have started the cardiotoxic therapy yet.",
            "criterions": [
                {
                    "exact_snippets": "Plan for treatment as cardiotoxic therapy.",
                    "criterion": "planned cardiotoxic therapy",
                    "requirements": [
                        {
                            "requirement_type": "planned",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "Patients for the feasibility study must be post cardiotoxic therapy",
                    "criterion": "cardiotoxic therapy status (feasibility study)",
                    "requirements": [
                        {
                            "requirement_type": "post-therapy",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "patients for the formal study should not have started the cardiotoxic therapy yet",
                    "criterion": "cardiotoxic therapy status (formal study)",
                    "requirements": [
                        {
                            "requirement_type": "pre-therapy",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Women of child-bearing potential must agree to use adequate contraception (hormonal or barrier method of birth control; abstinence) prior to study entry, for the duration of study participation. Should a woman become pregnant or suspect she is pregnant while participating in this study, she should inform her treating physician immediately.",
            "criterions": [
                {
                    "exact_snippets": "Women of child-bearing potential must agree to use adequate contraception (hormonal or barrier method of birth control; abstinence) prior to study entry, for the duration of study participation.",
                    "criterion": "contraception use",
                    "requirements": [
                        {
                            "requirement_type": "agreement to use contraception",
                            "expected_value": true
                        },
                        {
                            "requirement_type": "contraception method",
                            "expected_value": [
                                "hormonal",
                                "barrier method of birth control",
                                "abstinence"
                            ]
                        },
                        {
                            "requirement_type": "timing",
                            "expected_value": "prior to study entry and for the duration of study participation"
                        }
                    ]
                }
            ]
        },
        {
            "line": "* While all races and ethnicities will be included, subjects must be able to read and speak the English language, and or, the Spanish Language.",
            "criterions": [
                {
                    "exact_snippets": "all races and ethnicities will be included",
                    "criterion": "race and ethnicity",
                    "requirements": [
                        {
                            "requirement_type": "inclusion",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "subjects must be able to read and speak the English language",
                    "criterion": "English language ability",
                    "requirements": [
                        {
                            "requirement_type": "ability to read",
                            "expected_value": true
                        },
                        {
                            "requirement_type": "ability to speak",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "and or, the Spanish Language",
                    "criterion": "Spanish language ability",
                    "requirements": [
                        {
                            "requirement_type": "ability to read",
                            "expected_value": true
                        },
                        {
                            "requirement_type": "ability to speak",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Has not undergone a hysterectomy or bilateral oophorectomy; or",
            "criterions": [
                {
                    "exact_snippets": "Has not undergone a hysterectomy",
                    "criterion": "hysterectomy",
                    "requirements": [
                        {
                            "requirement_type": "history of procedure",
                            "expected_value": false
                        }
                    ]
                },
                {
                    "exact_snippets": "Has not undergone ... bilateral oophorectomy",
                    "criterion": "bilateral oophorectomy",
                    "requirements": [
                        {
                            "requirement_type": "history of procedure",
                            "expected_value": false
                        }
                    ]
                }
            ]
        }
    ],
    "exclusion_lines": [
        {
            "line": "* Claustrophobia.",
            "criterions": [
                {
                    "exact_snippets": "Claustrophobia.",
                    "criterion": "claustrophobia",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": false
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Subjects who are receiving any other investigational agents that are not compatible with the study.",
            "criterions": [
                {
                    "exact_snippets": "Subjects who are receiving any other investigational agents",
                    "criterion": "receipt of other investigational agents",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "investigational agents that are not compatible with the study",
                    "criterion": "compatibility of investigational agents with the study",
                    "requirements": [
                        {
                            "requirement_type": "compatibility",
                            "expected_value": false
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Sickle cell disease",
            "criterions": [
                {
                    "exact_snippets": "Sickle cell disease",
                    "criterion": "sickle cell disease",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Known Type 1 or Type 2 diabetes.",
            "criterions": [
                {
                    "exact_snippets": "Known Type 1 or Type 2 diabetes",
                    "criterion": "diabetes",
                    "requirements": [
                        {
                            "requirement_type": "type",
                            "expected_value": [
                                "Type 1",
                                "Type 2"
                            ]
                        },
                        {
                            "requirement_type": "known_status",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Patients for the feasibility study must be post cardiotoxic therapy",
            "criterions": [
                {
                    "exact_snippets": "must be post cardiotoxic therapy",
                    "criterion": "cardiotoxic therapy",
                    "requirements": [
                        {
                            "requirement_type": "treatment status",
                            "expected_value": "post"
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Non-MR compatible IV port.",
            "criterions": [
                {
                    "exact_snippets": "Non-MR compatible IV port",
                    "criterion": "IV port",
                    "requirements": [
                        {
                            "requirement_type": "MR compatibility",
                            "expected_value": false
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Hemolytic anemia",
            "criterions": [
                {
                    "exact_snippets": "Hemolytic anemia",
                    "criterion": "hemolytic anemia",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Subjects with known remote, macro, metastases will be excluded from this clinical trial because of their poor prognosis.",
            "criterions": [
                {
                    "exact_snippets": "Subjects with known remote, macro, metastases will be excluded",
                    "criterion": "metastases",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": false
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Any contraindication per MRI Screening Form (Appendix A attached) including, but not limited to:",
            "criterions": [
                {
                    "exact_snippets": "Any contraindication per MRI Screening Form (Appendix A attached)",
                    "criterion": "MRI contraindications",
                    "requirements": [
                        {
                            "requirement_type": "absence",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "eGFR ≤ 30 mL/min/1.73m2",
            "criterions": [
                {
                    "exact_snippets": "eGFR ≤ 30 mL/min/1.73m2",
                    "criterion": "eGFR",
                    "requirements": [
                        {
                            "requirement_type": "quantity",
                            "expected_value": {
                                "operator": "<=",
                                "value": 30,
                                "unit": "mL/min/1.73m2"
                            }
                        }
                    ]
                }
            ]
        },
        {
            "line": "* If the subject agrees to doing a cardiac function MRI scan with gadolinium based contrast agent intravenously:",
            "criterions": [
                {
                    "exact_snippets": "subject agrees to doing a cardiac function MRI scan",
                    "criterion": "cardiac function MRI scan",
                    "requirements": [
                        {
                            "requirement_type": "agreement to procedure",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "with gadolinium based contrast agent intravenously",
                    "criterion": "gadolinium based contrast agent administration",
                    "requirements": [
                        {
                            "requirement_type": "route of administration",
                            "expected_value": "intravenous"
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Female subjects who are already pregnant.",
            "criterions": [
                {
                    "exact_snippets": "Female subjects",
                    "criterion": "sex",
                    "requirements": [
                        {
                            "requirement_type": "value",
                            "expected_value": "female"
                        }
                    ]
                },
                {
                    "exact_snippets": "already pregnant",
                    "criterion": "pregnancy status",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Uncontrolled intercurrent illness including, but not limited to, ongoing or active infection, symptomatic congestive heart failure, unstable angina pectoris, cardiac arrhythmia, or psychiatric illness/social situations that would limit compliance with study requirements.",
            "criterions": [
                {
                    "exact_snippets": "Uncontrolled intercurrent illness including, but not limited to, ongoing or active infection",
                    "criterion": "intercurrent illness",
                    "requirements": [
                        {
                            "requirement_type": "control status",
                            "expected_value": "uncontrolled"
                        }
                    ]
                },
                {
                    "exact_snippets": "ongoing or active infection",
                    "criterion": "infection",
                    "requirements": [
                        {
                            "requirement_type": "status",
                            "expected_value": [
                                "ongoing",
                                "active"
                            ]
                        }
                    ]
                },
                {
                    "exact_snippets": "symptomatic congestive heart failure",
                    "criterion": "congestive heart failure",
                    "requirements": [
                        {
                            "requirement_type": "symptomatic",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "unstable angina pectoris",
                    "criterion": "angina pectoris",
                    "requirements": [
                        {
                            "requirement_type": "stability",
                            "expected_value": "unstable"
                        }
                    ]
                },
                {
                    "exact_snippets": "cardiac arrhythmia",
                    "criterion": "cardiac arrhythmia",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "psychiatric illness/social situations that would limit compliance with study requirements",
                    "criterion": "psychiatric illness or social situations limiting compliance",
                    "requirements": [
                        {
                            "requirement_type": "impact on compliance",
                            "expected_value": "would limit compliance with study requirements"
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Breast tissue expanders.",
            "criterions": [
                {
                    "exact_snippets": "Breast tissue expanders",
                    "criterion": "breast tissue expanders",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Metal Implants and devices contraindicated at 3T.",
            "criterions": [
                {
                    "exact_snippets": "Metal Implants and devices contraindicated at 3T",
                    "criterion": "metal implants and devices",
                    "requirements": [
                        {
                            "requirement_type": "contraindication at 3T",
                            "expected_value": true
                        }
                    ]
                }
            ]
        }
    ],
    "miscellaneous_lines": [],
    "failed_inclusion": [],
    "failed_exclusion": [],
    "failed_miscellaneous": []
}